621 related articles for article (PubMed ID: 25884510)
1. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
2. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N
Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644
[TBL] [Abstract][Full Text] [Related]
3. S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.
Švec X; Štorkánová H; Trinh-Minh T; Tran MC; Štorkánová L; Hulejová H; Oreská S; Heřmánková B; Bečvář R; Pavelka K; Vencovský J; Klingelhöfer J; Hussain RI; Hallén J; Šenolt L; Distler JHW; Tomčík M
Rheumatology (Oxford); 2024 Mar; 63(3):817-825. PubMed ID: 37314987
[TBL] [Abstract][Full Text] [Related]
4. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
5. Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
Klingelhöfer J; Grum-Schwensen B; Beck MK; Knudsen RS; Grigorian M; Lukanidin E; Ambartsumian N
Neoplasia; 2012 Dec; 14(12):1260-8. PubMed ID: 23308057
[TBL] [Abstract][Full Text] [Related]
6. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
7. Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.
Lu S; Zhang J; Liu D; Li G; Staveley-O'Carroll KF; Li Z; Wu JD
Clin Cancer Res; 2015 Nov; 21(21):4819-30. PubMed ID: 26106076
[TBL] [Abstract][Full Text] [Related]
8. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
[TBL] [Abstract][Full Text] [Related]
9. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
[TBL] [Abstract][Full Text] [Related]
11. Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties.
Bettum IJ; Vasiliauskaite K; Nygaard V; Clancy T; Pettersen SJ; Tenstad E; Mælandsmo GM; Prasmickaite L
Cancer Lett; 2014 Mar; 344(1):28-39. PubMed ID: 24215866
[TBL] [Abstract][Full Text] [Related]
12. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes.
Wang G; Zhang S; Fernig DG; Martin-Fernandez M; Rudland PS; Barraclough R
Oncogene; 2005 Feb; 24(8):1445-54. PubMed ID: 15608682
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.
Forst B; Hansen MT; Klingelhöfer J; Møller HD; Nielsen GH; Grum-Schwensen B; Ambartsumian N; Lukanidin E; Grigorian M
PLoS One; 2010 Apr; 5(4):e10374. PubMed ID: 20442771
[TBL] [Abstract][Full Text] [Related]
14. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
[TBL] [Abstract][Full Text] [Related]
15. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
16. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
17. A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies.
Huang A; Peng D; Guo H; Ben Y; Zuo X; Wu F; Yang X; Teng F; Li Z; Qian X; Qin FX
Sci Rep; 2017 Feb; 7():42687. PubMed ID: 28202921
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.
Grum-Schwensen B; Klingelhofer J; Berg CH; El-Naaman C; Grigorian M; Lukanidin E; Ambartsumian N
Cancer Res; 2005 May; 65(9):3772-80. PubMed ID: 15867373
[TBL] [Abstract][Full Text] [Related]
19. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
20. Clever-1/stabilin-1 controls cancer growth and metastasis.
Karikoski M; Marttila-Ichihara F; Elima K; Rantakari P; Hollmén M; Kelkka T; Gerke H; Huovinen V; Irjala H; Holmdahl R; Salmi M; Jalkanen S
Clin Cancer Res; 2014 Dec; 20(24):6452-64. PubMed ID: 25320356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
